7 results
The changes in expiratory flow limitation during increasing levels of external PEEP in COPD patients can be followed with the deltaXrs-8 using FOT.To evaluate whether the deltaXrs is good outcome parameter to determine the external PEEP level needed…
The aim is to investigate how effective the addition of several PEEP levels provided by regular CPAP is in patients with COVID-19 with moderate oxygenation problems.
To compare the efficacy of 7.5 mg/kg of crizanlizumab versus placebo on the annualized rate of VOC leading to healthcare visit, in addition to standard of careTo compare the efficacy of 5.0 mg/kg of crizanlizumab versus placebo on the annualized…
To characterize the safety, tolerability, and recommended phase 2 dose (RP2D) of each combination partner used with ruxolitinib (Part 1)To evaluate the preliminary efficacy of each novel ruxolitinib combination treatment arm (Parts 2 & 3)
The objective of this study is to collect basic function and patient satisfaction datafor observation and analysis.Specific objectives include the following:Evaluate the effect of component design on functional performance by comparing…
To evaluate the effect of crizanlizumab + standard of care compared to standard of care alone on albuminuria (ACR) decrease at 12 months
To study the effect of crizanlizumab on the hemodynamics of the cerebral vasculature (CBF and CVR)